|
Volumn 40, Issue 5, 2001, Pages 481-487
|
Diagnosis and monitoring of urological tumors using positron emission tomography
|
Author keywords
Bladder cancer; PET; Prostate cancer; Renal cell carcinoma; Testicular tumor
|
Indexed keywords
ACETIC ACID C 11;
ANTINEOPLASTIC AGENT;
FLUORODEOXYGLUCOSE F 18;
RADIOPHARMACEUTICAL AGENT;
ADENOMA;
BLADDER CARCINOMA;
CANCER ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER SIZE;
CANCER STAGING;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC VALUE;
DISEASE CLASSIFICATION;
DRUG ACCUMULATION;
DRUG CLEARANCE;
DRUG ELIMINATION;
DRUG TRANSPORT;
GERM CELL TUMOR;
GLUCOSE METABOLISM;
HUMAN;
IMAGE ANALYSIS;
INTERMETHOD COMPARISON;
KIDNEY CARCINOMA;
LYMPH NODE METASTASIS;
ONCOLOGY;
PARAAORTIC LYMPH NODE;
POSITRON EMISSION TOMOGRAPHY;
PREDICTION;
PRIORITY JOURNAL;
PROSTATE CARCINOMA;
PROSTATECTOMY;
REVIEW;
SENSITIVITY ANALYSIS;
TREATMENT OUTCOME;
URINARY TRACT CARCINOMA;
CARCINOMA, RENAL CELL;
FLUORODEOXYGLUCOSE F18;
HUMANS;
KIDNEY NEOPLASMS;
MALE;
PROSTATIC NEOPLASMS;
SEMINOMA;
SENSITIVITY AND SPECIFICITY;
TESTICULAR NEOPLASMS;
TOMOGRAPHY, EMISSION-COMPUTED;
URINARY BLADDER NEOPLASMS;
UROGENITAL NEOPLASMS;
|
EID: 0035731908
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: 10.1159/000049823 Document Type: Review |
Times cited : (55)
|
References (45)
|